Moll Wenden advised Scandinavian ChemoTech AB on the deal.Scandinavian ChemoTech AB completed the issuance of shares amounting to approximately SEK 14.85 million. ChemoTech is a Swedish medical technology…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
